Related Experiment Video
Updated: Feb 14, 2026

Monitoring Dynamic Changes In Mitochondrial Calcium Levels During Apoptosis Using A Genetically Encoded Calcium Sensor
Published on: April 1, 2011
Exendin-4 alleviates Aβ1-40-induced apoptosis and calcium dysregulation in RPE cells through the CHP1/NHE1 complex
Qinxin Shu1, Yuxin Lin1, Wenqi Su1
1Department of Ophthalmology, Chongqing Key Laboratory for the Prevention and Treatment of Major Blinding Eye Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing 400016, China.
Abstract:
Age-related macular degeneration (AMD) is a leading cause of visual impairment in elderly individuals and is influenced by various factors, such as age, genetics, and environmental conditions. While research into therapies for dry AMD is rapidly advancing, effective interventions are still lacking, underscoring the urgent need for new drug development. Recent studies have highlighted the multifaceted pharmacological activities of Exendin-4 (EX-4), including its anti-inflammatory, antioxidant, and antiapoptotic properties, along with its role in maintaining calcium homeostasis. The precise effects of EX-4 on AMD and its immediate target remain unclear. In this study, we investigated whether EX-4 could protect against Aβ1-40-induced AMD and explored the underlying mechanism. Our findings indicated that pretreatment with EX-4 alleviated apoptosis and restored calcium homeostasis both in vivo and in vitro. To identify the target of EX-4, we employed proteome microarrays and pulldown LC‒MS/MS analyses. Our results revealed that EX-4 bound to Calcineurin-like EF-hand protein 1(CHP1), reducing CHP1 protein expression in a concentration-dependent manner. This interaction led to a subsequent reduction in apoptosis and the normalization of intracellular Ca2+ levels through the CHP1/NHE1 complex. Furthermore, we demonstrated that the inhibitory effects of EX-4 on apoptosis and calcium signaling were reversed by knocking down or overexpressing CHP1 in vitro. Finally, in AMD mice with CHP1-deficient retinas, the beneficial effects of EX-4 on apoptosis and calcium signaling were partially attenuated. In summary, our results suggest that the interaction of EX-4 with CHP1 has therapeutic potential for AMD, likely through alleviating apoptosis and restoring calcium homeostasis.
Insights
Exendin-4 (EX-4) protects against age-related macular degeneration (AMD) by targeting Calcineurin-like EF-hand protein 1 (CHP1). This interaction reduces apoptosis and restores calcium homeostasis, offering therapeutic potential for AMD treatment.
Area of Science:
- Ophthalmology
- Molecular Biology
- Pharmacology
Background:
- Age-related macular degeneration (AMD) is a major cause of vision loss in older adults, with limited effective treatments for dry AMD.
- Exendin-4 (EX-4) exhibits anti-inflammatory, antioxidant, and antiapoptotic properties, and influences calcium homeostasis, but its role in AMD is unknown.
- Developing novel therapeutic strategies for AMD is crucial due to the lack of effective interventions.
Purpose of the Study:
- To investigate the protective effects of Exendin-4 (EX-4) against Aβ1-40-induced age-related macular degeneration (AMD).
- To elucidate the underlying molecular mechanism and identify the direct target of EX-4 in AMD.
- To assess the therapeutic potential of the EX-4/CHP1 interaction for AMD treatment.
Main Methods:
- In vivo and in vitro experiments were conducted to evaluate the effects of EX-4 on apoptosis and calcium homeostasis.
- Proteome microarrays and pulldown LC-MS/MS were used to identify the target protein of EX-4.
- In vitro studies involved knocking down or overexpressing Calcineurin-like EF-hand protein 1 (CHP1).
- Experiments were performed in AMD mice with CHP1-deficient retinas.
Main Results:
- Pretreatment with EX-4 alleviated apoptosis and restored calcium homeostasis in AMD models.
- EX-4 was found to bind directly to Calcineurin-like EF-hand protein 1 (CHP1), reducing its expression concentration-dependently.
- The EX-4/CHP1 interaction reduced apoptosis and normalized intracellular Ca2+ levels via the CHP1/NHE1 complex.
- CHP1 modulation reversed EX-4's effects on apoptosis and calcium signaling in vitro.
- The therapeutic benefits of EX-4 in AMD mice were partially reduced in CHP1-deficient retinas.
Conclusions:
- Exendin-4 (EX-4) demonstrates therapeutic potential for age-related macular degeneration (AMD).
- The interaction between EX-4 and Calcineurin-like EF-hand protein 1 (CHP1) is a key mechanism underlying EX-4's protective effects.
- Targeting the EX-4/CHP1 pathway may offer a novel strategy for treating AMD by alleviating apoptosis and restoring calcium homeostasis.
Related Concept Videos
Apoptosis
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Induced Pluripotent Stem Cells
Complex Numbers
Formation of Complex Ions

